Oren Zimhony

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel

Tal Brosh‐Nissimov, Efrat Orenbuch‐Harroch, Michal Chowers et al. · Clinical Microbiology and Infection · 2021 · 363 citations · Full text

Vaccination, Vaccinology, Bnt162b2 Vaccine Breakthrough +9

Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis

Oren Zimhony, Jeffery S. Cox, John T. Welch et al. · Nature Medicine · 2000 · 260 citations

Pulmonary Tuberculosis, Biosynthesis, Biochemistry +8

Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream Infection

Ronen Ben‐Ami, Keren Olshtain‐Pops, Michal Krieger et al. · Antimicrobial Agents and Chemotherapy · 2012 · 174 citations · Full text

Recent Exposure, Fluconazole-resistant Candida Isolates, Antimicrobial Chemotherapy +16

<i>Bartonella koehlerae</i> , a New Cat-Associated Agent of Culture-Negative Human Endocarditis

Boaz Avidor, Merav Graidy, Gabi Efrat et al. · Journal of Clinical Microbiology · 2004 · 171 citations · Full text

Domestic Cats, Culture-negative Human Endocarditis, Pathogen Detection +14

Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis

Christian Carrière, Paul Riska, Oren Zimhony et al. · Journal of Clinical Microbiology · 1997 · 108 citations · Full text

Tuberculosis Prevention, Bacteriophage, Molecular Biology +21